Cambridge Investment Research Advisors’s Agenus AGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,712
Closed -$21K 3612
2025
Q1
$21K Sell
13,712
-387
-3% -$1.11K ﹤0.01% 3451
2024
Q4
$39K Sell
14,099
-7,510
-35% -$27.8K ﹤0.01% 3391
2024
Q3
$118K Sell
21,609
-1,952
-8% -$14.6K ﹤0.01% 3243
2024
Q2
$395K Buy
23,561
+22,342
+1,833% +$270K ﹤0.01% 2480
2024
Q1
$14K Sell
1,219
-201
-14% -$2.67K ﹤0.01% 3275
2023
Q4
$24K Sell
1,420
-173
-11% -$2.87K ﹤0.01% 3134
2023
Q3
$36K Buy
1,593
+463
+41% +$13.1K ﹤0.01% 3062
2023
Q2
$36K Sell
1,130
-116
-9% -$3.71K ﹤0.01% 3104
2023
Q1
$37K Buy
1,246
+66
+6% +$2.79K ﹤0.01% 3066
2022
Q4
$56K Sell
1,180
-114
-9% -$5.79K ﹤0.01% 2968
2022
Q3
$52K Sell
1,294
-82
-6% -$4.18K ﹤0.01% 2933
2022
Q2
$52K Hold
1,376
﹤0.01% 2939
2022
Q1
$66K Sell
1,376
-958
-41% -$51.8K ﹤0.01% 3060
2021
Q4
$147K Buy
2,334
+151
+7% +$11.9K ﹤0.01% 2968
2021
Q3
$225K Buy
2,183
+331
+18% +$37.4K ﹤0.01% 2709
2021
Q2
$200K Buy
1,852
+923
+99% +$69.2K ﹤0.01% 2840
2021
Q1
$50K Buy
929
+4
+0.4% +$289 ﹤0.01% 2805
2020
Q4
$58K Sell
925
-38
-4% -$2.82K ﹤0.01% 2642
2020
Q3
$76K Buy
963
+259
+37% +$20.1K ﹤0.01% 2422
2020
Q2
$54K Hold
704
﹤0.01% 2376
2020
Q1
$34K Sell
704
-26
-4% -$1.63K ﹤0.01% 2210
2019
Q4
$58K Buy
730
+46
+7% +$3.09K ﹤0.01% 2346
2019
Q3
$35K Hold
684
﹤0.01% 2301
2019
Q2
$40K Buy
+684
New +$37.4K ﹤0.01% 2157
2018
Q4
Sell
-577
Closed -$24K 2147
2018
Q3
$24K Buy
+577
New +$22.7K ﹤0.01% 2220

Other funds holding AGEN

Cambridge Investment Research Advisors's AGEN Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of Agenus (AGEN) in Q2 2025, closing a stake of 13,712 shares — an estimated $21K sold.

Cambridge Investment Research Advisors first reported a position in AGEN in Q3 2018 and held it in 25 quarters. The position peaked at $395K in Q2 2024. 91 funds tracked by Wall St. Rank hold AGEN as of Q2 2025.

  • Cambridge Investment Research Advisors reported no remaining Agenus position as of Q2 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 13,712 Agenus shares in Q2 2025, an estimated $21K.
  • Cambridge Investment Research Advisors first reported a position in Agenus in Q3 2018 and held it in 25 quarters.
  • Cambridge Investment Research Advisors's Agenus position peaked at $395K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held Agenus as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.